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Early life adversity (ELA) increases the risk for multiple age-related diseases, such as 
diabetes type 2 and cardiovascular disease. As prevalence is high, ELA poses a major 
and global public health problem. Immunosenescence, or aging of the immune system, 
has been proposed to underlie the association between ELA and long-term health con-
sequences. However, it is unclear what drives ELA-associated immunosenescence and 
which cells are primarily affected. We investigated different biomarkers of immunosenes-
cence in a healthy subset of the EpiPath cohort. Participants were either parent-reared 
(Ctrl, n = 59) or had experienced separation from their parents in early childhood and 
were subsequently adopted (ELA, n =  18). No difference was observed in telomere 
length or in methylation levels of age-related CpGs in whole blood, containing a hetero-
geneous mixture of immune cells. However, when specifically investigating T cells, we 
found a higher expression of senescence markers (CD57) in ELA. In addition, senescent 
T cells (CD57+) in ELA had an increased cytolytic potential compared to senescent cells 
in controls. With a mediation analysis we demonstrated that cytomegalovirus (CMV) 
infection, which is an important driving force of immunosenescence, largely accounted 
for elevated CD57 expression observed in ELA. Leukocyte telomere length may obscure 
cell-specific immunosenescence; here, we demonstrated that the use of cell surface 
markers of senescence can be more informative. Our data suggest that ELA may 
increase the risk of CMV infection in early childhood, thereby mediating the effect of ELA 
on T cell-specific immunosenescence. Thus, future studies should include CMV as a 
confounder or selectively investigate CMV seronegative cohorts.
Keywords: early life adversity, immunosenescence, cD57, cytomegalovirus, telomere length, T cells
Abbreviations: ANOVA, analysis of variance; CMV, cytomegalovirus; CTQ, childhood trauma questionnaire; Ctrl, control; 
EBV, Epstein–Barr virus; HSV-1, herpes simplex 1; IQR, interquartile range; PBMCs, peripheral blood mononuclear cells; 
ASPA, aspartoacylase; CM, central memory; ELA, early life adversity; EM, effector memory; GraB, granzyme B; HLA-DR, 
human leukocyte antigen–antigen D related; ITGA2B, integrin alpha 2b; MFI, median fluorescent intensity; PDE4C, phospho-
diesterase; T/S, relative telomere to single copy gene ratio; CTL, cytotoxic T lymphocyte; TEMRA, terminally differentiated 
effector memory; Th cell, T helper cell.
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inTrODUcTiOn
Adverse and stressful events in childhood, such as parental loss, 
low childhood socioeconomic status, or institutionalization, have 
been associated with elevated levels of inflammation (1) and an 
increased risk for multiple age-related diseases, such as cardio-
vascular disease (2, 3) and type 2 diabetes (4). As many as 39% 
of children worldwide are estimated to experience one or more 
forms of early life adversity (ELA) (5), placing a high economic 
burden on health-care systems—and society in general—through 
medical costs and lost productivity (6). Although ELA is a major 
and global public health problem, it is currently unknown how its 
detrimental consequences can be prevented or reversed.
Many efforts have been made to understand the mechanisms 
underlying long-term effects of ELA. One of the mechanisms 
proposed is accelerated aging of the immune system, also known 
as immunosenescence (7, 8). Immunosenescence refers to the 
process of progressive deterioration of immune functions that 
go hand in hand with normal aging (9). Although senescence 
is characterized by an irreversible arrest in cell proliferation, 
senescent cells are not inactive, but show elevated levels of 
cytotoxicity and produce more pro-inflammatory cytokines (10). 
Accelerated immunosenescence negatively impacts health, lead-
ing to increased lifetime morbidity and mortality (11, 12). Thus, 
if ELA affects the rate of immunosenescence, this may explain an 
increased risk and earlier onset of age-related disorders.
Indeed, evidence is accumulating that ELA accelerates immu-
nosenescence. One of the most used proxies for immunosenes-
cence is telomere length. Telomeres are tandem repeats at the 
ends of chromosomes that shorten with age and with every cell 
division (13). For instance, naïve T cells have longer telomeres 
than terminally differentiated T  cells that went through more 
replication cycles (14). A considerable number of studies have 
investigated telomere length in individuals with a history of ELA, 
but results vary in size and significance. Ridout et al. included 41 
studies (n = 30,773) in a meta-analysis and could demonstrate 
a significant association between ELA and shorter telomeres, 
although with a small-to-medium effect size (15). A number of 
tissues were included, including buccal cells, but the majority of 
studies focused specifically on leukocytes.
However, leukocytes are a heterogeneous mixture of immune 
cells; ELA may affect some cell types more than others. Few 
studies have investigated immunosenescence in specific immune 
subtypes. To the best of our knowledge, only Cohen et al. meas-
ured telomere length in a specific immune subset. They investi-
gated a terminally differentiated and senescent subset of T cells, 
CD8+CD28− cells and found shorter telomeres associated with 
low childhood socioeconomic status (16). These data suggest that 
ELA specifically affects the aging of T cells, although other cell 
types are probably affected as well.
T  cell senescence is characterized by a loss of naïve T  cell 
populations, which are essential to combat novel antigens from 
infection or vaccination. At the same time, memory cell types 
such as effector memory (EM) and terminally differentiated 
T cells gradually increase during aging (17). It is possible to differ-
entiate between naïve, central memory (CM), EM, and terminally 
differentiated T cell populations, using lineage markers such as 
CD45RA and CCR7 (18). Moreover, several cell surface markers 
have been identified that are either up- or downregulated as T cell 
senescence progresses, such as CD57, which allow for cell type-
specific analysis of immunosenescence (19).
Apart from telomere length and surface molecules as biomarkers 
for senescence, there is emerging literature on various epigenetic 
indicators of cellular aging, based on an accumulation of age-related 
changes in DNA methylation profiles (20). Epigenetic indices have 
been shown to predict mortality and biological age independently 
from telomere length, suggesting that epigenetic aging targets 
an alternative pathway to telomere length (21). Furthermore, 
epigenetic aging signatures have been shown to predict age more 
precisely than telomere length (22). The association between ELA, 
telomere shortening, and age-related diseases suggests that also 
the “epigenetic clock” ticks faster in ELA. Early results imply that 
psychological factors and early environment can predict epigenetic 
aging (23–25). However, to date, few studies have addressed this in 
ELA specifically, and results are ambiguous (8).
It remains an open question as to what drives ELA-associated 
immunosenescence. Besides ELA, several other environmental 
factors have been found to modulate the rate of immunosenes-
cence, such as persistent viral infections (26). Herpes simplex 
virus (HSV), Epstein–Barr virus (EBV), and cytomegalovirus 
(CMV) are among the most prevalent viral infections that 
establish latency after primary infection and reactivate when the 
immune system is compromised. Latent infections with CMV in 
particular are believed to play an important role in immunose-
nescence and are associated with age-related alterations of T cell 
immunity (27, 28). Moreover, ELA increases the risk of herpes 
infections and has been implicated in increased reactivation in 
children and adults (29–31).
In this study, we investigated T  cell-specific immunosenes-
cence (T cell differentiation and CD57 expression) in participants 
with and without a history of ELA, in addition to epigenetic aging 
at age-related CpGs. Participants in the ELA group had experi-
enced separation from their parents in early childhood and were 
subsequently adopted, which is a standard model of ELA. This 
study cohort is a healthy subset of the EpiPath cohort, excluding 
all participants with acute or chronic diseases. With a mediation 
analysis we examined whether CMV titers may account for 
immunosenescence observed in ELA.
MaTerials anD MeThODs
Participants
Healthy participants were selected from the EpiPath cohort 
(Elwenspoek et  al., manuscript under review, Journal of 
Immunology), based on absence of chronic or acute diseases and 
medication use, and adequate number of bio-banked peripheral 
blood mononuclear cells (PBMCs) for investigation. The EpiPath 
cohort was recruited between 2014 and 2016 from Luxembourg 
and The Greater Region Saar-Lor-Lux and consisted of young 
adults, aged 18–35 years, that were either parent-reared (Ctrl) or 
experienced separation from their parents in early childhood fol-
lowed by adoption (ELA). 59 Ctrl and 18 ELA participants were 
included in this study (Figure  S1 in Supplementary Material). 
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One adoptee was directly adopted from the birth family, all others 
experienced the additional stress of institutionalization, which 
is considered to be a form of social deprivation and structural 
neglect (32). All participants gave their written informed consent. 
The study design was approved by the Ethics Review Panel of 
University of Luxembourg (ERP, No 13-002) and the National 
Research Ethics Committee (CNER, No201303/10) in compli-
ance with the Declaration of Helsinki.
Blood samples
Blood samples were collected in sodium heparin-coated tubes for 
PBMC isolation and in EDTA-coated tubes for DNA and plasma 
isolation. To minimize inter-individual variation, all samples 
were collected at the end of the morning (ca. 11:30 a.m. ±30 min); 
participants were asked to refrain from smoking, strenuous 
physical exercise, and drinking caffeinated or alcoholic beverages 
on the day of the clinical visit; women were either using hormonal 
contraceptives or were in the luteal phase of their menstrual cycle. 
Furthermore, participants’ age and sex were recorded. At a second 
visit, information about the age at adoption was obtained and the 
childhood trauma questionnaire (CTQ) was administered.
cMV Titers
EDTA blood samples were centrifuged at 4°C within 15 min of 
blood collection and the plasma phase was collected. Plasma sam-
ples were transported on ice and stored at −80°C within 6 h until 
further analysis. Plasma was used in a 1:21 dilution to determine 
CMV IgG antibody indexes by ELISA (Calbiotech, El Cajon, 
CA, USA). As a control, HSV-1 and EBV IgG antibody indexes 
were also determined with ELISAs from the same company. The 
ELISAs were performed following manufacturer’s instructions, in 
duplicate, and read on a SpectraMax Plus 384 Microplate Reader 
(Molecular Devices, Berkshire, UK).
Telomere length and age-related cpgs
DNA isolation and telomere length measurements in the EpiPath 
were reported previously in Elwenspoek et al. (manuscript under 
review, Journal of Immunology). Methylation levels were measured 
at age-related CpGs in aspartoacylase (ASPA) (cg02228185), integ-
rin alpha 2b (ITGA2B) (cg25809905), and PDE4CA (cg17861230) 
according to (22). In brief, unmethylated cytosine residues in each 
DNA sample were converted to uracil with a bisulfite treatment 
(EpiTect Bisulfite Kit, Qiagen, Venlo, Netherlands) and regions of 
interest were amplified with PCR (PyroMark PCR Kit, Qiagen) in 
the bisulfite-modified DNA according to the manufacturer’s pro-
tocols. PCR products were pyrosequenced on a Pyromark ID with 
Pyrogold reagents (Biotage, Uppsala, Sweden) and methylation 
levels were analyzed with Pyro Q-CpG SW (Biotage). A sample 
of pooled DNA was run in each batch as internal control, which 
was used to calculate relative methylation levels. These relative 
methylation levels were used for all further analyses.
PBMc isolation and Flow cytometry
All cell culture products were from Lonza BioWhittaker 
(Versviers, Belgium), unless otherwise stated. PBMCs were 
isolated within 3  h of sample collection using Ficoll-Paque 
density gradient centrifugation. Briefly, EDTA blood was diluted 
in sterile 1× PBS, layered over Ficoll-Paque™ PLUS (Fisher 
Scientific, Erembodegem-Aalst, Belgium) in Leucosep tubes 
(Greiner Bio-One, Vilvoorde, Belgium), and centrifuged for 
5 min at 300 g. PBMCs were washed twice with PBS and stored 
at 4.106 cells/1 mL/aliquot in 80% Heat-Inactivated Fetal Bovine 
Serum (Gibco, Paisley, UK) and 20% DMSO (Sigma-Aldrich, 
Saint-Louis, CA, USA) in liquid nitrogen until analyzed.
Peripheral blood mononuclear cells were thawed quickly and 
rested overnight at 37°C, 5% CO2 in RPMI 1640 medium, with 
10% Heat-Inactivated Fetal Bovine Serum, 1% penicillin/strep-
tomycin, 1% sodium pyruvate (Gibco), 1% non-essential amino 
acids (Gibco), and 1% ultra-glutamine. PBMCs (1.107 cells/mL) 
were incubated with GolgiPlug and GolgiStop (final concentra-
tions of 2 and 1  µL/mL, respectively, BD BioSciences) for 5  h 
at 37°C, 5% CO2. All subsequent steps were performed at 4°C 
and protected from ambient light. PBMCs were washed twice 
with 1× FACS Buffer [1× PBS, 1% bovine serum albumin Cohn 
fraction V (Sigma-Aldrich, Saint-Louis, CA, USA), 0.1% NaN3, 
2 mM EDTA (Sigma-Aldrich), pH 8.0] and stained with a LIVE/
DEAD dye and antibodies against CD4, CD3, CD8, CD45RA, 
human leukocyte antigen–antigen D related (HLA-DR), CCR7, 
and CD57 (Table S1 in Supplementary Material) for 30  min. 
Then, PBMCs were permeabilized and fixed with BD Cytofix/
Cytoperm™ (BD BioSciences, San Diego, CA, USA) for 20 min, 
followed by a 30 min intracellular staining of granzyme B (GraB) 
and perforin (Table S1 in Supplementary Material).
Thirty thousand lymphocyte events were acquired on the BD 
LSRFortessa (BD BioSciences) using FACSDiva (BD BioSciences, 
version 8.0). Data analysis was performed with FlowJo (version 
10.2, Tree Star, Ashland, OR, USA) using the gating strategy 
presented in Figure S2 in Supplementary Material. T  cell 
differentiation was determined by CCR7 and CD45RA expres-
sion: naïve (CCR7+CD45RA+), CM (CCR7+CD45RA−), EM 
(CCR7−CD45RA−), and terminally differentiated cells (terminally 
differentiated effector memory; TEMRA, CCR7−CD45RA+). 
Relative numbers of cells (e.g., CD57+ cells) and median fluores-
cent intensity (MFI) were analyzed.
statistical analysis
Group differences in telomere length, relative methylation levels 
of age-related CpGs, CMV titers, CTQ sum scores, and age at 
adoption were investigated with a Wilcoxon rank sum test with 
continuity correction. In the initial analysis, we constructed 
linear regression models to investigate group differences in cell 
types (flow cytometry data), in which “cell type” was included 
as outcome variable and both groups and experimental day were 
included as fixed effects; the latter to account for variation between 
experiments. Cell percentages were transformed with the arcsine 
transformation (asin(sign(x) × sqrt(abs(x)))) to stabilize variance 
and MFI values with a log-transformation to approximate nor-
mality. Analyses of variance (ANOVAs) were performed on each 
model to test the significance of the group effect. The Benjamini–
Hochberg procedure was performed on all p-values generated by 
the ANOVAs to correct for multiplicity (33). When plotting CMV 
titers, a “high” and “low” antibody group emerged. Log(CMV 
titers) = −1.2 was chosen as cutoff. To investigate the relation-
ship between CMV levels and CD57 expression, Spearman’s rank 
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FigUre 1 | Markers for senescence. Relative telomere length in T/S (a), methylation levels at the age-related CpGs ASPA, ITGA2B, and PDE4C (B–D), respectively. 
Statistics: Wilcoxon rank sum test with continuity correction. Abbreviations: Ctrl, control; ASPA, aspartoacylase; ELA, early life adversity; ITGA2B, integrin alpha 2b; 
PDE4C, phosphodiesterase; T/S, relative telomere to single copy gene ratio.
TaBle 1 | Participant characteristics.
all (n = 77) ctrl (n = 59) ela (n = 18) p-Value
Age (median years [IQR]) 22 [20–24] 21 [20–23] 23 [20–25] 0.702
Sex (% female) 61.0 59.3 66.7 0.777
Age at adoptiona  
(median months [IQR])
0 [0–0] 0 [0–0] 4.3 [0–15] <0.001
Childhood trauma  
(median CTQ  
scores [IQR])
1.2 [1.1–1.4] 1.2 [1.1–1.4] 1.2 [1.1–1.4] 0.934
Statistics: For continuous variables, the Wilcoxon rank sum test with continuity 
correction was applied and for categorical variables the Pearson’s chi-squared test 
with Yates’ continuity correction.
Ctrl, control; CTQ, childhood trauma questionnaire; ELA, early life adversity; IQR, 
interquartile range.
a“Age at adoption” was used as a proxy of ELA severity (36); therefore, controls were 
set to 0.
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correlation rho were determined. To investigate the mediating 
effect of CMV on the association between ELA and senescent 
cells, a mediation analysis was performed in R [version 3.3.3 (34) 
using mediation version 4-4.5 (35)]. Because age at adoption can 
be considered to be proportional to the duration of adversity and 
can thus be used as proxy for ELA severity (36), in the mediation 
analysis, age at adoption (months) was used as continuous vari-
able for ELA, in which controls were set to 0. p-Values below 5% 
were considered significant.
resUlTs
Participant characteristics
The Ctrl and ELA groups did not differ in age or sex. The median 
age at adoption was 3.4 months. Adoptions took place at an early 
age, so participants had no memory of the time before adop-
tion. Consequently, the CTQ scores, based on the participant’s 
memory of trauma experiences before age 16, reflects experiences 
after adoption, which was similar between groups. Thus, apart 
from the adoption, the experimental groups were comparable in 
age, sex, subsequent childhood trauma exposure, and all partici-
pants were in good health (Table 1; Figure S1 in Supplementary 
Material).
Telomere length and epigenetic aging
Immunosenescence in leukocytes was measured with two distinct 
techniques. First, as previously reported, we did not observe a 
difference in telomere length between the two groups in the com-
plete EpiPath cohort (Elwenspoek et al., manuscript under review, 
Journal of Immunology). Also in the subset of participants used in 
this investigation, which only included healthy participants, there 
was no effect of ELA on telomere length (median [interquartile 
range; IQR]; Ctrl: 1.2 [0.8–1.8], ELA: 1.1 [0.8–1.7], p =  0.714; 
Figure 1A). Second, methylation levels at three age-related CpGs 
that have been linked to chronological and biological age were 
measured (22). We found similar methylation levels in ELA 
and Ctrl (ASPA Ctrl: 1.01 [0.97–1.03], ELA: 1.01 [0.98–1.04], 
p = 0.452; ITGA2B Ctrl: 1.05 [1.00–1.12], ELA: 1.08 [1.02–1.12], 
p =  0.438; phosphodiesterase (PDE4C) Ctrl: 0.99 [0.93–1.10], 
ELA: 1.05 [0.97–1.13], p = 0.258; Figures 1B–D).
T cell-specific senescence
A 10-color flow cytometry panel was used to investigate cell-
specific immunosenescence. Although immunosenescence 
is related to changes in the ratio of naïve and memory T cells, 
the ratios and numbers of naïve, CM, EM, and terminally dif-
ferentiated T cells (TEMRA) were similar between Ctrl and ELA 
(data not shown). However, we found a higher number of T cells 
expressing the senescence marker CD57. ELA was associated 
with a significant increase in both the total number of T  cells 
(linear regression, adjusted p =  0.017) and T helper (Th) cell 
subset (adjusted p = 0.038), expressing CD57 (Figure 2A). The 
cytotoxic T lymphocytes (CTLs) showed a similar trend toward 
higher CD57, albeit this did not reach statistical significance 
(adjusted p = 0.061). The increase in CD57+ cells between Ctrl 
and ELA appeared to be highest in Th cells, showing almost a 
1.5-fold increase, and lowest in overall lymphocytes, consisting 
of a mixture of B cells, T cells, and NK cells.
There was also a significant group effect on the intensity of 
CD57 fluorescence (MFI, T  cells: adjusted p <  0.001, Th cells: 
p  =  0.024, CTLs: p  =  0.001; Figures  2B,C), suggesting that 
CD57 expression was higher in ELA. The median fluorescent 
intensity (MFI) of CD57 was 5–10% higher in ELA than Ctrl 
on lymphocytes, total T cells, Th, and CTLs. CTLs showed the 
C
T cells
CD4 Th cells
CD8 CTLs
*
*** **
* #
*
A
B
FS
C
-A
C
ou
nt
FS
C
-A
C
ou
nt
FS
C
-A
C
ou
nt
APC-CD57
APC-CD57
APC-CD57
CD57- CD57+
CD57- CD57+
CD57- CD57+
0.0
0.2
0.4
0.6
Ctrl ELA
Group
Ar
cs
in
e(
%
 o
f T
 c
el
ls
)
CD57+ T cells
0.0
0.1
0.2
0.3
Ctrl ELA
Group
Ar
cs
in
e(
%
 o
f C
D
4 
Th
 c
el
ls
)
CD57+ CD4 Th cells
0.0
0.2
0.4
0.6
Ctrl ELA
Group
Ar
cs
in
e(
%
 o
f C
D
8 
C
TL
s)
CD57+ CD8 CTLs
6
8
10
12
Ctrl ELA
Group
lo
g e
(M
FI
)
CD57+ T cells
6
8
10
12
Ctrl ELA
Group
lo
g e
(M
FI
)
CD57+ CD4 Th cells
6
8
10
12
Ctrl ELA
Group
lo
g e
(M
FI
)
CD57+ CD8 CTLs
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lowest increase in CD57 expression. As expected (37), CD57+ 
cells were not equally distributed among the different stages of 
T cell differentiation (Figure 3). In both Th and CTL subsets, EM 
and TEMRA cells had the highest number of CD57+ cells. The 
increase in CD57+ cells in ELA was mainly happening in EM Th 
cells (Figure 3A) and in both TEMRA and EM CTLs (Figure 3B).
cytolytic Potential and activation
Cytolytic potential was measured by GraB and perforin staining. 
As expected (38), CD57+ cells had higher GraB, perforin, and 
HLA-DR expression (Figures 4A,B), suggesting higher cytolytic 
potential and a higher activation status in senescent Th and CTLs. 
When comparing the senescent cells (CD57+) between groups, 
GraB and perforin expression was elevated in ELA, although 
the expression of the activation marker HLA-DR was similar 
(Figures 4C,D). The level of fluorescent intensity of neither GraB 
nor perforin differed between the groups (data not shown).
influence of cMV infection
In the final step of the analysis, we investigated whether CMV 
infection had a mediating effect on the relationship between 
ELA and immunosenescence. Initially, we tested the difference 
in CMV titers between the two groups. Indeed, titers were higher 
in the ELA group (medium [IQR], Ctrl: 0.13 [0.09–0.64], ELA: 
0.82 [0.33–0.94]; p = 0.023; Figure 5A), caused by an increased 
number of seropositive participants. To further investigate the 
relationship between CMV titers and CD57 expression, we 
divided the control participants into two groups with either 
“high” or “low” CMV titers. Participants with high CMV titers 
had significantly higher levels of CD57+CD4 EM (p <  0.001) 
and TEMRA (p <  0.001) cells, as well as higher CD57+ in all 
subsets of CD8 (Naïve, p = 0.007; CM, p < 0.001; EM, p = 0.001; 
TEMRA, p = 0.020; Figure 5B). Subsequently, we tested the cor-
relation between the number of senescent cells (CD57+) or the 
level of CD57 expression on these cells and CMV titers. Indeed, 
we found highly significant and strong correlations in T  cells, 
and its subsets Th and CTLs (Figure 5C). In contrast, titers of 
EBV and HSV, herpes viruses that cause similar lifelong latent 
infections, were not elevated in ELA (EBV: Ctrl: 0.91 [0.53–1.78], 
ELA: 1.43 [0.72–2.10], p =  0.213; HSV: Ctrl: 0.22 [0.12–1.78], 
ELA: 0.29 [0.13–1.82], p = 0.906) nor where they correlated to 
the number of senescent T cells (EBV: rho = 0.10, p = 0.370; HSV: 
rho = −0.01, p =  0.900). A causal mediation analysis demon-
strated a large mediating effect of CMV titers (Figure 6A), which 
could explain 27.4% of the total effect of ELA (age at adoption) on 
T cell senescence (Table 2). Interestingly, when investigating ELA 
as mediator of the effect of CMV on senescent T cells, we only 
found a trend (Table 3; Figure 6B). Furthermore, there was a clear 
correlation between the age of adoption and CMV titer (Figure S3 
in Supplementary Material, Spearman’s rho = 0.71, p = 0.0071), 
while there was no clear correlation between CMV titers and age 
at time of study participation among control participants (Figure 
S4 in Supplementary Material, Spearman’s rho = 0.17, p = 0.15). 
This suggests that ELA is not just a marker for CMV exposure, 
but that there are other ELA-related factors involved (Table  3; 
Figure 6B).
DiscUssiOn
In this study, we have shown that ELA is associated with higher 
levels of T  cell senescence in healthy participants (selection of 
EpiPath cohort). Even though there was no difference in telomere 
length or methylation levels at age-related CpGs in leukocytes, we 
observed a significant difference when specifically investigating 
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T cells. Not only did we find a higher number of senescent cells 
(CD57+), these cells also expressed higher levels of CD57, a 
cell surface marker for senescence, and were more cytotoxic in 
ELA compared to controls. The difference was highest in cells 
in later stages of differentiation, such as EM and TEMRA cells, 
while differentiation per se was not altered in ELA (according to 
lineage markers CD45RA and CCR7). Control participants with 
“high” CMV titers showed a higher number of senescent cells, 
compared to controls with “low” titers, which was particularly 
apparent in late differentiated effector Th cells (EM and TEMRA). 
Importantly, we found that the effect of ELA on immunosenes-
cence was associated with CMV infection specifically, rather than 
being the consequence of continued reactivation of latent viruses 
in general.
Our findings have important implications for this literature 
on senescence in ELA. Most evidence for accelerated immunose-
nescence in ELA comes from telomere length, but none of these 
studies have accounted for CMV infections. Our results suggest 
that the association between ELA and shorter telomeres—or 
immunosenescence in general—may have been largely mediated 
by CMV infection. Although we did not observe shorter telomeres 
in this study nor in the complete EpiPath cohort (Elwenspoek 
et  al., manuscript under review, Journal of Immunology), we 
did find higher numbers of CD57+ T cells in ELA. It has been 
demonstrated previously that this cell type has shorter telomeres 
(39). The large inter-individual variation in telomere length and 
the heterogeneity of leukocytes, most probably masked this effect.
Cytomegalovirus is a likely mediator between ELA and 
immunosenescence. First of all, because there is a clear link 
between CMV infection and immunosenescence. CMV infection 
is related to expanding populations of specific memory T cells 
(40, 41), and a shrinking population of naïve T cells (42), similar 
to what is observed in aging (17). CMV seropositivity has been 
shown to reduce life expectancy by almost 4 years in an elderly 
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population, especially due to an increase in cardiovascular deaths 
(43). In agreement with the results presented here, CMV-specific 
T  cell have been found to express senescence markers, such 
as CD57 and KLRG1 (44), but are still highly cytotoxic (40). 
Interestingly, CMV infection affects reactivation of other latent 
viruses. Reactivation of HSV increased with age, but only in CMV 
seropositive individuals (45). Similarly, only in CMV seropositive 
individuals, EBV reactivation was associated with inflammatory 
FigUre 6 | Mediation models. (a) ELA as independent variable, T cell immunosenescence as dependent variable, and CMV titers as mediator variable. (B) CMV 
titers as independent variable, T cell immunosenescence as dependent variable, and ELA as mediator variable. In these models, ELA was treated as continuous 
variable (age at adoption) and all Ctrl were set to 0. Abbreviations: ACME, average causal mediation effect; ADE, average direct effect, CMV, cytomegalovirus; ELA, 
early life adversity.
TaBle 2 | Causal mediation analysis: cytomegalovirus as mediator.
estimate 95% ci lower 95% ci upper p-Value
ACME 0.000633 0.000315 0.002202 0.00**
ADE 0.001674 −0.001614 0.002890 0.07
Total effect 0.002307 0.000586 0.003754 0.03*
Prop. mediated 0.274381 0.099298 0.661469 0.03*
Non-parametric bootstrap CIs with the percentile method. *p < 0.05; **p < 0.01.
ACME, average causal mediation effect; ADE, average direct effect; CI, confidence 
interval; prop., probability.
TaBle 3 | Causal mediation analysis: early life adversity as mediator.
estimate 95% ci lower 95% ci upper p-Value
ACME 0.00681 −0.00105 0.01637 0.08
ADE 0.03673 0.01905 0.05431 0.00***
Total effect 0.04354 0.02472 0.06183 0.00***
Prop. mediated 0.15635 −0.02606 0.38365 0.08
Non-parametric bootstrap CIs with the percentile method. ***p < 0.001.
ACME, average causal mediation effect; ADE, average direct effect; CI, confidence 
interval; prop., probability.
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markers in circulation (46). Inflammation and chronic antigen 
exposure as a results of viral reactivation further enhances immu-
nosenescence (10). Finally, CMV infection has been related to 
reduced lymphocyte telomere length (47) and is associated with 
decreased telomerase activity (48), an enzyme that can partially 
counteract telomere loss. However, these studies looked at total 
T cells and leukocytes, respectively, so it is unclear whether this 
effect is limited to CMV-specific T cells or also affects telomere 
biology in other immune cells.
Second, there is reason to believe that children in adverse 
circumstances are at higher risk for CMV infection. For instance, 
the likelihood of CMV infection is higher in children raised in 
poverty and low socioeconomic status (49, 50). Poverty is reliable 
predictor of more severe forms of ELA such as childhood abuse 
and neglect (51–53). There is no clear epidemiological data on 
the prevalence of infection in international adoptees, as were 
included in this study. However, most adopted children have been 
institutionalized prior to adoption, which arguably increases the 
risk for CMV infection, as is the case for day-care center attend-
ance (50). This is supported by a US study that found a 45% 
seroprevalence of CMV in a group of 247 internationally adopted 
children between 1 and 2 years of age (54) —much higher com-
pared to the 21–22% reported in a German population sample of 
1- to 2-year olds (50). Indeed, we found higher CMV titers in the 
adoptees compared to controls.
Although our statistical analysis suggests complete mediation 
by CMV, it is unlikely that CMV infection alone can explain the 
negative health consequences related to ELA. Especially because 
among seropositive individuals, ELA is associated with impaired 
viral control and increased CMV reactivation (29, 49, 55). 
TaBle 4 | Countries of origin among early life adversity participants.
country Participants (n)
Brazil 1
China 2
Columbia 1
Peru 4
Romania 5
Thailand 1
Unknowna 4
aParticipant did not know or preferred not to answer.
FigUre 7 | Proposed interaction between early life adversity (ELA) and 
cytomegalovirus (CMV) to cause immunosenescence.
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Furthermore, among CMV+ children ELA was associated with 
an increased percentage of senescent CTLs (CD8+CD28−CD57+ 
cells) (56). Unfortunately, our sample size did not allow for further 
stratification according to CMV serostatus. Thus, even though 
CMV infection alone has been related to immunosenescence, 
ELA appears to amplify this effect.
Psychological stress plays an important role in viral reactiva-
tion (57), possibly due to immunosuppressive effect of the stress 
hormone cortisol that could compromise an effective response of 
the immune system. Interestingly, ELA has been association with 
an altered stress response (58). When we incorporate our CMV 
mediation model into the existing literature, it becomes clear that 
CMV and ELA interact on several levels, resulting in accelerated 
immunosenescence (Figure 7). We speculate that ELA increases 
the risk for CMV infection, leading to an immune response that 
drives T  cell differentiation and thereby further accelerating 
immunosenescence. The effect of ELA on the stress system may 
subsequently compromise viral control, leading to more frequent 
viral reactivation, which further promotes immunosenescence. 
Viral reactivation results in elevated levels of inflammation, which 
in turn may accelerate immunosenescence via oxidative stress. 
Immune functions decline, ultimately resulting in an earlier onset 
of age-related diseases. However, to date, there is insufficient data 
to validate this hypothesis.
strengths and limitations
Differences in ethnic background between the Ctrl and ELA 
group and small sample size were the main limitations in this 
study. Nevertheless, we have taken several measures to reduce 
variability. ELA participants came from various regions in the 
world, and there was not one particular region overrepresented, 
so we believe that a possible effect of genetic background would 
have been limited (Table 4). Furthermore, all blood samples were 
collected at the same time of day, which minimized the impact of 
circadian rhythms of hormones and immune cells on the results. 
It is important to note that in the original sample of the EpiPath 
cohort, ELA participants were almost four times more likely to 
have a chronic disease than controls. Participants with any chronic 
disease had higher CMV titers than healthy participants, which 
may have been secondary to medication use or the disease itself. 
To avoid effects of present disease and medication on the immune 
variables, we specifically selected a healthy subset of the cohort. 
Finally, we accounted for possible variation between experimental 
days by including this as a factor in the final statistical model.
It is important to note that freezing and thawing as well as 
resting overnight of PBMCs may have introduced artifacts in 
the analysis. For instance, resting overnight before staining has 
been shown to decrease viability and can change T cell phenotype 
(59). Nevertheless, we could repeat our previous findings on fresh 
samples of the same cohort concerning HLA-DR expression on 
T cells (Elwenspoek et al., manuscript under review, Journal of 
Immunology).
cOnclUsiOn
By using specific cell surface markers of senescence, we were able 
to detect higher levels of T cell senescence associated with ELA in 
a relatively heterogeneous sample of individuals. Moreover, these 
differences were present many years after ELA had occurred. 
Leukocyte telomere length may obscure cell specific immunose-
nescence, therefore, the use of cell surface markers of senescence 
or measuring telomere length on isolated cell subsets will be 
more informative. Although CMV appears to play an important 
role, it is unclear whether CMV infection is a prerequisite for 
ELA-related immunosenescence. To the best of our knowledge, 
there is no data showing an association between accelerated 
immunosenescence and ELA in CMV seronegative individuals. 
Future studies should include CMV as a confounder or selectively 
investigate CMV seronegative cohorts.
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